✦ LIBER ✦

Interaction of vasoactive intestinal peptide (VIP), gastric inhibitory peptide (GIP), glucagon-29 and -37 on HGT-1 human gastric cancer cells

✍ Scribed by Emami, S.; Chastre, E.; Bodéré, H.; Gespach, C.; Bataille, D.; Rosselin, G.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gastric inhibitory peptide (GIP), pancre

✍ Christian Gespach; Shahin Emami; Gabriel Rosselin 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 590 KB

Functional receptors for VIP, GIP, Gluca

✍ Emami, Shahin; Chastre, Eric; Bodéré, Hélène; Gespach, Christian; Bataille, Domi 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 733 KB

Effect of truncated glucagon-like peptid

✍ A.B. Hansen; C.P. Gespach; G.E. Rosselin; J.J. Holst 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 312 KB

Identification and characterization of r

✍ Emami, S.; Gespach, C.; Laboisse, C.; Rosselin, G. 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Effects of hypoxia on the plasma concent

✍ P. Guilloteau; J.A. Chayvialle; R. Toullec; C. Bernard; A. Mouats; J.F. Grongnet 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Interaction of VIP and related peptides

✍ Emami, S.; Gespach, C.; Rosselin, G. 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 86 KB